[{"Assets_0_Q3_USD":194251000.0,"CommonStockSharesOutstanding_0_Q3_shares":11969928.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-16806000.0,"NetIncomeLoss_1_Q3_USD":-14025000.0,"NetIncomeLoss_3_Q3_USD":-30247000.0,"StockholdersEquity_0_Q3_USD":136667000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":237000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":12169000.0,"Ticker":"ALBO","CIK":"1322505","name":"ALBIREO PHARMA, INC.","OfficialName":"Albireo Pharma Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"688702712.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]